Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study

Autor: Ree, Anne Hansen, Dueland, Svein, Folkvord, Sigurd, Hole, Knut H, Seierstad, Therese, Johansen, Marianne, Abrahamsen, Torveig W, Flatmark, Kjersti
Zdroj: In Lancet Oncology 2010 11(5):459-464
Databáze: ScienceDirect